Heeji Lim

Cheongju-si, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Time Course Characterization of Protective Immune Responses Following BCG Vaccination in BALB/c Mice.

Time Course Characterization of Protective Immune Responses Following BCG Vaccination in BALB/c Mice.

Journal: Pathogens (Basel, Switzerland)
Published: February 06, 2026

Exploratory Evaluation of Peptide-Based Immunization Targeting Fusion Glycoprotein-Derived Epitopes of Nipah Virus in Murine Model.

Exploratory Evaluation of Peptide-Based Immunization Targeting Fusion Glycoprotein-Derived Epitopes of Nipah Virus in Murine Model.

Journal: Vaccines
Published: November 27, 2025

Design and Preliminary Immunogenicity Evaluation of Nipah Virus Glycoprotein G Epitope-Based Peptide Vaccine in Mice.

Design and Preliminary Immunogenicity Evaluation of Nipah Virus Glycoprotein G Epitope-Based Peptide Vaccine in Mice.

Journal: Vaccines
Published: February 26, 2025

Long-term Response to SARS-CoV-2 mRNA Vaccine in Adolescents.

Long-term Response to SARS-CoV-2 mRNA Vaccine in Adolescents.

Journal: The Pediatric infectious disease journal
Published: January 31, 2025

Bacillus Calmette-Guérin Vaccination Promotes Efficient and Comprehensive Immune Modulation in Guinea Pig Models.

Bacillus Calmette-Guérin Vaccination Promotes Efficient and Comprehensive Immune Modulation in Guinea Pig Models.

Journal: Vaccines
Published: January 30, 2025

Immunogenicity Analysis of Chikungunya Virus DNA Vaccine Based on Mutated Putative N-Linked Glycosylation Sites of the Envelope Protein.

Immunogenicity Analysis of Chikungunya Virus DNA Vaccine Based on Mutated Putative N-Linked Glycosylation Sites of the Envelope Protein.

Journal: Vaccines
Published: August 23, 2024

Immunogenicity and Neutralization of Recombinant Vaccine Candidates Expressing F and G Glycoproteins against Nipah Virus.

Immunogenicity and Neutralization of Recombinant Vaccine Candidates Expressing F and G Glycoproteins against Nipah Virus.

Journal: Vaccines
Published: July 26, 2024

Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants.

Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants.

Journal: PloS one
Published: July 19, 2023

SARS-CoV-2 mRNA Vaccine Elicits Sustained T Cell Responses Against the Omicron Variant in Adolescents.

SARS-CoV-2 mRNA Vaccine Elicits Sustained T Cell Responses Against the Omicron Variant in Adolescents.

Journal: Immune network
Published: April 17, 2023

Humoral Immune Response of Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Prime-Boost Vaccination against SARS-CoV-2 Variants in Korea.

Humoral Immune Response of Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Prime-Boost Vaccination against SARS-CoV-2 Variants in Korea.

Journal: Infection & chemotherapy
Published: August 09, 2022

Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules.

Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules.

Journal: Frontiers in cellular and infection microbiology
Published: May 19, 2022

Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein.

Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein.

Journal: Virology
Published: March 24, 2022
Showing 1-12 of 18

Last Updated: 09/26/2026